https://orcid.org/0000-0002-4013-4316
References
- Oti VB. Nanoparticles and its implications in HIV/AIDS therapy. Curr Drug Discov Technol. 2020;17(4):448–456. doi: 10.2174/1570163816666190620111652.
- Muller JT, et al. 2024) Emtricitabine. In: StatPearls. [Internet]. Treasure Island (FL): StatPearls Publishing;. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539853/
- EMTRIVA® (emtricitabine) capsule. for oral use (fda.gov) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021500s029lbl.pdf.
- Fateme DA, et al. Nano drug-delivery systems for management of AIDS: liposomes, dendrimers, gold and silver nanoparticles. Nanomedicine. 2023;18(3):279–302.
- Fotooh Abadi L, Damiri F, Zehravi M, et al. Novel nanotechnology-based approaches for targeting HIV reservoirs. Polymers (Basel). 2022;14(15):3090. doi: 10.3390/polym14153090.
- Liao G, Fang J, Li Q, et al. Ag-based nanocomposites: synthesis and applications in catalysis. Nanoscale. 2019;11(15):7062–7096. doi: 10.1039/c9nr01408j.
- Ravichandran K, Prasheetha PK, Arun T, et al. 2018. Synthesis of nanocomposites. In Synthesis of Inorganic Nanomaterials- Micro and Nano Technologies (pp. 141–168). Woodhead Publishing.
- Wu Y, et al. Preparation of hydrophobically modified carboxylated pullulan nanoparticles for evaluating the effect of hydrophobic substitution on the properties and functions of nanoparticles. Mat Tech. 2022;37(10):1467–1477.
- Singh RS, Kaur N, Kennedy JF, et al. Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting. Carbohydr Polym. 2015;123:190–207. doi: 10.1016/j.carbpol.2015.01.032.
- Yang WZ, et al. 2008) Preparation and physicochemical characteristics of self-assembled nanoparticles of cholesterol succinate modified pullulan conjugates. In 7th AsianPacific Conference on Medical and Biological Engineering: APCMBE 2008 22–25 Apr. 2008 Springer Berlin Heidelberg: 13–17
- Bhattacharyya S. In vitro/in vivo evaluation of elastic nano-lipid carriers of aztreonam for pneumonic lungs. Pharm Nanotechnol. 2023;11(3):294–302. doi: 10.2174/2211738511666230223141759.
- Dissolution Methods. (fda.gov) https://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults.cfm.
- Salimi A, Sharif Makhmal Zadeh B, Kazemi M, et al. Preparation and optimization of polymeric micelles as an oral drug delivery system for deferoxamine mesylate: in vitro and ex vivo studies. Res Pharm Sci. 2019;14(4):293–307. doi: 10.4103/1735-5362.263554.
- Leblanc AF, Huang KM, Uddin ME, et al. Murine pharmacokinetic studies. Bio Protoc. 2018;8(20):e3056. doi: 10.21769/BioProtoc.3056.
- Miatmoko A, Faradisa AA, Jauhari AA, et al. The effectiveness of ursolic acid niosomes with chitosan coating for prevention of liver damage in mice induced by n-nitrosodiethylamine. Sci Rep. 2022;12(1):21397. doi: 10.1038/s41598-022-26085-2.
- Kikkawa R, Fujikawa M, Yamamoto T, et al. In vivo hepatotoxicity study of rats in comparison with in vitro hepatotoxicity screening system. J Toxicol Sci. 2006;31(1):23–34. doi: 10.2131/jts.31.23.
- Bhattacharyya S, Sudheer P, Das K, et al. Experimental design supported liposomal aztreonam delivery: in vitro studies. Adv Pharm Bull. 2021;11(4):651–662. doi: 10.34172/apb.2021.074.